Fig. 1 | The NLRP3 inflammasome is an upstream activator of IL-1β and IL-18. NodThera is employing novel chemistry to create small molecules that inhibit the NLRP3 inflammasome that have now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback